Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin ...

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

Biotechnology venture capital is recovering from its slide and investors are expressing optimism about 2025, even as they ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

For 25 years, it was Joe Panetta’s job to tell the story of San Diego’s biotechnology community to the world. And the job ...

Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.

Biotech has a big footprint in Massachusetts, and according to a 2023 report, women make up less than 6% of leadership roles ...